Amedisys (AMED) News Today $92.36 -0.38 (-0.41%) Closing price 03/25/2025 04:00 PM EasternExtended Trading$92.37 +0.01 (+0.01%) As of 03/25/2025 04:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 Time Period 6,000 Shares in Amedisys, Inc. (NASDAQ:AMED) Bought by Cannon Global Investment Management LLCCannon Global Investment Management LLC acquired a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 6,000 shares of the health services provider's stoMarch 25 at 6:05 AM | marketbeat.comMRP Capital Investments LLC Has $29,000 Stake in Amedisys, Inc. (NASDAQ:AMED)MRP Capital Investments LLC decreased its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 97.6% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 315 shares of the health services provider's stock after sellingMarch 22, 2025 | marketbeat.comBirnam Oak Advisors LP Makes New Investment in Amedisys, Inc. (NASDAQ:AMED)Birnam Oak Advisors LP acquired a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 174,383 shares of the health services provider's stock, valued at approximately $15,832,000. AmedisyMarch 18, 2025 | marketbeat.comOppenheimer moving to Perform from Not Rated on AmedisysMarch 17, 2025 | markets.businessinsider.comCharles Schwab Investment Management Inc. Has $32.85 Million Position in Amedisys, Inc. (NASDAQ:AMED)Charles Schwab Investment Management Inc. lifted its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 4.5% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 361,812 shares of the health services provider's stock afteMarch 17, 2025 | marketbeat.comRaymond James maintains Amedisys stock Market Perform ratingMarch 12, 2025 | investing.comWealthfront Advisers LLC Invests $72.97 Million in Amedisys, Inc. (NASDAQ:AMED)Wealthfront Advisers LLC acquired a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm acquired 803,727 shares of the health services provider's stock, valued at approximatMarch 12, 2025 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Shares Acquired by Alpine Associates Management Inc.Alpine Associates Management Inc. boosted its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 3.2% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 888,120 shares of the health services provider's stock after buying an additionalMarch 10, 2025 | marketbeat.comBurren Capital Advisors Ltd Purchases Shares of 23,044 Amedisys, Inc. (NASDAQ:AMED)Burren Capital Advisors Ltd acquired a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 23,044 shares of the health services provider's stocMarch 9, 2025 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Receives Consensus Recommendation of "Hold" from BrokeragesShares of Amedisys, Inc. (NASDAQ:AMED - Get Free Report) have been assigned a consensus recommendation of "Hold" from the six brokerages that are covering the firm, MarketBeat.com reports. Five research analysts have rated the stock with a hold recommendation and one has issued a buy recommendatiMarch 9, 2025 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Shares Purchased by Bank of New York Mellon CorpBank of New York Mellon Corp lifted its position in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 22.6% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 298,870 shares of the health services provider's stockMarch 9, 2025 | marketbeat.comAmedisys' (AMED) "Equal Weight" Rating Reaffirmed at StephensStephens reissued an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a research report on Tuesday.March 4, 2025 | marketbeat.comSilphium Asset Management Ltd Has $6.81 Million Stake in Amedisys, Inc. (NASDAQ:AMED)Silphium Asset Management Ltd decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 37.3% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 75,000 shares of the healthMarch 3, 2025 | marketbeat.comWilliam Blair Has Negative Estimate for Amedisys Q1 EarningsAmedisys, Inc. (NASDAQ:AMED - Free Report) - Equities researchers at William Blair lowered their Q1 2025 earnings per share (EPS) estimates for shares of Amedisys in a report issued on Thursday, February 27th. William Blair analyst M. Larew now expects that the health services provider will postMarch 1, 2025 | marketbeat.comAmedisys, Inc.: Amedisys Reports Fourth Quarter and Year End 2024 Financial ResultsFebruary 28, 2025 | finanznachrichten.deAmedisys, Inc.: Amedisys Reports Fourth Quarter and Year End 2024 Financial ResultsFebruary 28, 2025 | finanznachrichten.deWilliam Blair Reaffirms Their Hold Rating on Amedisys (AMED)February 28, 2025 | markets.businessinsider.comDecoding Amedisys Inc (AMED): A Strategic SWOT InsightFebruary 28, 2025 | gurufocus.comAmedisys (NASDAQ:AMED) Issues Quarterly Earnings ResultsAmedisys (NASDAQ:AMED - Get Free Report) posted its quarterly earnings data on Wednesday. The health services provider reported $0.96 EPS for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a net margin of 3.57% and a return on equity of 12.20%.February 27, 2025 | marketbeat.comAmedisys (NASDAQ:AMED) Issues Earnings ResultsAmedisys (NASDAQ:AMED - Get Free Report) released its quarterly earnings data on Wednesday. The health services provider reported $0.96 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.05 by ($0.09). Amedisys had a return on equity of 12.20% and a net margin of 3.57%.February 27, 2025 | marketbeat.comAmedisys reports Q4 adjusted EPS 96c, consensus $1.06February 26, 2025 | markets.businessinsider.comAmedisys Inc (AMED) Reports Q4 and Full Year 2024 Financial ResultsFebruary 26, 2025 | gurufocus.comAmedisys, Inc. Reports Fourth Quarter and Year-End 2024 Financial Results Amid Merger with UnitedHealth GroupFebruary 26, 2025 | quiverquant.comAmedisys Reports Fourth Quarter and Year End 2024 Financial ResultsFebruary 26, 2025 | globenewswire.comUnitedHealth Stock Falls on Report DOJ Is Probing Its Medicare Billing PracticesFebruary 23, 2025 | msn.comAmedisys, Inc. (NASDAQ:AMED) Shares Sold by Olympiad Research LPOlympiad Research LP trimmed its stake in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 72.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 5,865 shares of the health services provider's stock afteFebruary 23, 2025 | marketbeat.comWolverine Asset Management LLC Sells 20,815 Shares of Amedisys, Inc. (NASDAQ:AMED)Wolverine Asset Management LLC decreased its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 59.8% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 13,966 shares of the health services pFebruary 23, 2025 | marketbeat.comState of New Jersey Common Pension Fund D Buys 2,967 Shares of Amedisys, Inc. (NASDAQ:AMED)State of New Jersey Common Pension Fund D raised its holdings in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 14.6% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 23,324 shares of the health serviFebruary 23, 2025 | marketbeat.comUnitedHealth tumbles 7% on WSJ report the DOJ is investigating Medicare billing practicesFebruary 22, 2025 | msn.comUS probes UnitedHealth's Medicare billing practices, WSJ reportsFebruary 21, 2025 | msn.comDOJ launches probe into UnitedHealth’s Medicare billing practices after investigative reportsFebruary 21, 2025 | msn.comDOJ launches probe into UnitedHealth's Medicare billing practices: reportFebruary 21, 2025 | msn.comEmpowered Funds LLC Takes Position in Amedisys, Inc. (NASDAQ:AMED)Empowered Funds LLC purchased a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 3,500 shares of the health services provider's stock, vaFebruary 21, 2025 | marketbeat.comAmedisys ticks lower as DOJ trial to block UnitedHealth deal set for Oct. 27 or laterFebruary 20, 2025 | msn.comAmedisys, Inc. (NASDAQ:AMED) Sees Significant Growth in Short InterestAmedisys, Inc. (NASDAQ:AMED - Get Free Report) saw a large increase in short interest in January. As of January 31st, there was short interest totalling 2,550,000 shares, an increase of 7.1% from the January 15th total of 2,380,000 shares. Approximately 8.0% of the company's stock are sold short. Based on an average daily trading volume, of 525,800 shares, the short-interest ratio is currently 4.8 days.February 17, 2025 | marketbeat.comABC Arbitrage SA Takes Position in Amedisys, Inc. (NASDAQ:AMED)ABC Arbitrage SA purchased a new position in Amedisys, Inc. (NASDAQ:AMED - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 27,782 shares of the health services provider's stock, valFebruary 16, 2025 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Receives Consensus Rating of "Hold" from AnalystsAmedisys, Inc. (NASDAQ:AMED - Get Free Report) has earned an average rating of "Hold" from the six ratings firms that are currently covering the firm, MarketBeat reports. Five analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 1 year targFebruary 12, 2025 | marketbeat.comAmedisys' (AMED) Equal Weight Rating Reaffirmed at StephensStephens reiterated an "equal weight" rating and set a $101.00 target price on shares of Amedisys in a research note on Wednesday.February 12, 2025 | marketbeat.comAmedisys, Inc. (NASDAQ:AMED) Shares Acquired by State of Alaska Department of RevenueState of Alaska Department of Revenue increased its stake in Amedisys, Inc. (NASDAQ:AMED - Free Report) by 448.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 20,737 shares of the hFebruary 12, 2025 | marketbeat.comAmedisys (AMED) to Release Earnings on WednesdayAmedisys (NASDAQ:AMED) will be releasing earnings before the market opens on Wednesday, February 19, Financial Modeling Prep reports.February 12, 2025 | marketbeat.comUnitedHealth says DOJ antitrust complaint ‘mischaracterizes’ evidenceFebruary 11, 2025 | msn.comUnitedHealth Group to answer DOJ's complaint in Amedisys dealFebruary 9, 2025 | msn.comUnitedHealth drops motion to dismiss DOJ’s antitrust case in $3.3B Amedisys dealFebruary 8, 2025 | msn.comKKR-backed Cotiviti close to deal to buy Edifecs for $3B - FTFebruary 5, 2025 | msn.comAmedisys Honors 47 Employees With Annual Spirit of Excellence AwardFebruary 4, 2025 | markets.businessinsider.comCalamos Advisors LLC Boosts Position in Amedisys, Inc. (NASDAQ:AMED)Calamos Advisors LLC grew its position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) by 22.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 487,444 shares of the health services provider's stock after purchFebruary 4, 2025 | marketbeat.comAmedisys Inc (AMED) Honors 47 Employees with Spirit of Excellence AwardsFebruary 3, 2025 | gurufocus.comAmedisys Honors 47 Employees With Annual Spirit of Excellence AwardFebruary 3, 2025 | globenewswire.comFY2026 EPS Estimates for Amedisys Raised by Leerink PartnrsAmedisys, Inc. (NASDAQ:AMED - Free Report) - Equities research analysts at Leerink Partnrs lifted their FY2026 earnings per share estimates for shares of Amedisys in a report released on Wednesday, January 29th. Leerink Partnrs analyst W. Mayo now anticipates that the health services provider wilFebruary 3, 2025 | marketbeat.comFY2024 EPS Estimates for Amedisys Lowered by Leerink PartnrsAmedisys, Inc. (NASDAQ:AMED - Free Report) - Investment analysts at Leerink Partnrs dropped their FY2024 EPS estimates for shares of Amedisys in a report released on Wednesday, January 29th. Leerink Partnrs analyst W. Mayo now forecasts that the health services provider will post earnings of $4.3January 31, 2025 | marketbeat.com Remove Ads Get Amedisys News Delivered to You Automatically Sign up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter. Email Address AMED Media Mentions By Week AMED Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMED News Sentiment▼1.580.77▲Average Medical News Sentiment AMED News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMED Articles This Week▼34▲AMED Articles Average Week Remove Ads Get Amedisys News Delivered to You Automatically Sign up to receive the latest news and ratings for AMED and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies DVA News Today CHE News Today CRVL News Today MD News Today AMN News Today CCRN News Today LH News Today DGX News Today OPCH News Today BTSG News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMED) was last updated on 3/26/2025 by MarketBeat.com Staff From Our PartnersDOGE could send 6 AI stocks through the roofStay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...Weiss Ratings | SponsoredNew “Trump” currency proposed in DCAccording to one of the most connected men in Washington… A surprising new bill was just introduced in Wash...Paradigm Press | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredGold Hits $3,000… Here’s How You Can Get More for Under $20With gold surging to record highs, currently trading above $3,000 an ounce, and central banks aggressively sto...The Oxford Club | SponsoredElon x DOGE = Government backed Smokescreen???While the mainstream media obsesses over Elon's new Department of Government Efficiency... A much BIGGER st...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedisys, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedisys With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
